Barriers and Facilitators to End of Life Care in Huntington’s Disease – A review of the literature

Ruth Hosken
{"title":"Barriers and Facilitators to End of Life Care in Huntington’s Disease – A review of the literature","authors":"Ruth Hosken","doi":"10.21307/ajon-2017-020","DOIUrl":null,"url":null,"abstract":"Abstract Background: The advanced stage of Huntington’s Disease has been a secondary focus to support and treatment interventions, resulting in limited knowledge about best practice end of life care for both individuals and their families. This article analyses the current state of knowledge about late stage Huntington’s Disease and end of life planning for people with the disease. Methods: A literature search was conducted in the electronic databases using the following search terms: ‘Huntington’s Disease’ AND ‘end of life OR palliative care OR late stage OR advanced’. Forty two articles were identified for review. Discussion: People with Huntington’s Disease think about their end of life wishes, but often do not discuss these with their doctors. Incorporation of an early palliative approach into a multidisciplinary neurology service is widely regarded as best practice and should include the early introduction of end of life planning, however many clinicians are not comfortable with discussing end of life care. This paper synthesises the available information and makes recommendations regarding advance care plans for people with HD. Conclusion: Initiation of a palliative approach early in Huntington’s Disease has the potential to improve management of symptoms, increase the likelihood of advance care plans being developed and improve the overall quality of life throughout the duration of the illness; therefore, all clinicians working with people with Huntington’s Disease should have an understanding of palliative approaches.","PeriodicalId":32533,"journal":{"name":"Australasian Journal of Neuroscience","volume":"272 1","pages":"33 - 42"},"PeriodicalIF":0.0000,"publicationDate":"2019-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Australasian Journal of Neuroscience","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21307/ajon-2017-020","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Abstract Background: The advanced stage of Huntington’s Disease has been a secondary focus to support and treatment interventions, resulting in limited knowledge about best practice end of life care for both individuals and their families. This article analyses the current state of knowledge about late stage Huntington’s Disease and end of life planning for people with the disease. Methods: A literature search was conducted in the electronic databases using the following search terms: ‘Huntington’s Disease’ AND ‘end of life OR palliative care OR late stage OR advanced’. Forty two articles were identified for review. Discussion: People with Huntington’s Disease think about their end of life wishes, but often do not discuss these with their doctors. Incorporation of an early palliative approach into a multidisciplinary neurology service is widely regarded as best practice and should include the early introduction of end of life planning, however many clinicians are not comfortable with discussing end of life care. This paper synthesises the available information and makes recommendations regarding advance care plans for people with HD. Conclusion: Initiation of a palliative approach early in Huntington’s Disease has the potential to improve management of symptoms, increase the likelihood of advance care plans being developed and improve the overall quality of life throughout the duration of the illness; therefore, all clinicians working with people with Huntington’s Disease should have an understanding of palliative approaches.
亨廷顿氏病临终关怀的障碍和促进因素-文献综述
背景:晚期亨廷顿舞蹈病一直是支持和治疗干预的次要焦点,导致对个人及其家庭的最佳实践临终关怀的知识有限。本文分析了关于晚期亨廷顿舞蹈病的知识现状和对患有这种疾病的人的生命规划。方法:在电子数据库中使用以下搜索词进行文献检索:“亨廷顿氏病”和“生命终结或姑息治疗或晚期或晚期”。确定了42篇文章进行审查。讨论:患有亨廷顿氏病的人会考虑他们的临终愿望,但通常不会和医生讨论这些。将早期姑息治疗方法纳入多学科神经病学服务被广泛认为是最佳实践,应该包括早期引入生命终结计划,然而许多临床医生对讨论生命终结护理感到不舒服。这篇论文综合了现有的信息,并对HD患者的提前护理计划提出了建议。结论:在亨廷顿氏病早期开始姑息治疗方法有可能改善症状管理,增加制定提前护理计划的可能性,并改善整个疾病期间的整体生活质量;因此,所有与亨廷顿舞蹈病患者打交道的临床医生都应该了解姑息治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
5
审稿时长
10 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书